Literature DB >> 15746671

The effect of vaginal candidiasis on the shedding of human immunodeficiency virus in cervicovaginal secretions.

Arsenio Spinillo1, Francesca Zara, Barbara Gardella, Eleonora Preti, Roberta Mainini, Renato Maserati.   

Abstract

OBJECTIVE: The purpose of this study was to evaluate the influence of symptomatic vulvovaginal candidiasis on the shedding of HIV-1 in cervicovaginal secretions of HIV-1-infected women. STUDY
DESIGN: We obtained paired blood and cervicovaginal lavage samples from 66 HIV-infected women with symptomatic vulvovaginal candidiasis, and 249 HIV-infected control patients without genital infection. HIV-1 RNA in plasma, proviral HIV-1 DNA, HIV-1 RNA transcripts, and cell-free HIV-1 RNA in cervicovaginal secretions were quantitatively evaluated by competitive polymerase chain reaction (cPCR) and reverse transcriptase PCR (cRT-PCR). We used logistic regression on ordered data to assess the influence of vulvovaginal candidiasis on the HIV-1 load in cervicovaginal secretions adjusting for potential confounders.
RESULTS: Overall, the amount of HIV-1 RNA in plasma was significantly correlated with HIV-1 DNA (Spearman rank 0.153 +/- 0.059, P = .006), HIV-1 RNA transcripts (Spearman rank 0.169 +/- 0.058, P = .003), and cell free HIV-1 RNA (Spearman rank 0.185 +/- 0.059, P = .001) load in cervicovaginal secretion. Forty-eight out of 182 (26.4%) patients who tested negative for HIV-1 RNA in plasma were positive for HIV-DNA in their cervicovaginal secretions. In logistic regression analysis vulvovaginal candidiasis was significantly associated with increasing loads of HIV-1 RNA transcripts (Odds ratio [OR] 1.97, 95% CI 1.09-3.57, P = .025) and cell free HIV-1 RNA (OR 2.03, 95% CI 1.10-3.73, P = .02) in cervicovaginal secretions.
CONCLUSION: In HIV-infected women, vulvovaginal candidiasis is associated with an increased number of copies of cell-associated and cell-free HIV-1 RNA in cervicovaginal secretions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15746671     DOI: 10.1016/j.ajog.2004.10.609

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Targeting Trojan Horse leukocytes for HIV prevention.

Authors:  Deborah J Anderson; Joseph A Politch; Adam M Nadolski; Caitlin D Blaskewicz; Jeffrey Pudney; Kenneth H Mayer
Journal:  AIDS       Date:  2010-01-16       Impact factor: 4.177

2.  Interaction between lactobacilli, bacterial vaginosis-associated bacteria, and HIV Type 1 RNA and DNA Genital shedding in U.S. and Kenyan women.

Authors:  Caroline Mitchell; Jennifer E Balkus; David Fredricks; Congzhou Liu; Jennifer McKernan-Mullin; Lisa M Frenkel; Christina Mwachari; Amneris Luque; Susan E Cohn; Craig R Cohen; Robert Coombs; Jane Hitti
Journal:  AIDS Res Hum Retroviruses       Date:  2012-11-05       Impact factor: 2.205

3.  Associations between genital tract infections, genital tract inflammation, and cervical cytobrush HIV-1 DNA in US versus Kenyan women.

Authors:  Caroline Mitchell; Jennifer E Balkus; Jennifer McKernan-Mullin; Susan E Cohn; Amneris E Luque; Christina Mwachari; Craig R Cohen; Robert Coombs; Lisa M Frenkel; Jane Hitti
Journal:  J Acquir Immune Defic Syndr       Date:  2013-02-01       Impact factor: 3.731

4.  Lower Genital Tract Infections in HIV-Infected Women: Can We Afford to Miss?

Authors:  Meenakshi Lallar; Smiti Nanda; Rajesh Nandal
Journal:  J Obstet Gynaecol India       Date:  2014-09-21

5.  Real-time PCR quantification of genital shedding of herpes simplex virus (HSV) and human immunodeficiency virus (HIV) in women coinfected with HSV and HIV.

Authors:  Jérôme Legoff; Hicham Bouhlal; Gérard Grésenguet; Helen Weiss; Nzambi Khonde; Hakim Hocini; Nathalie Désiré; Ali Si-Mohamed; Jean de Dieu Longo; Cécile Chemin; Eric Frost; Jacques Pépin; Jean-Elie Malkin; Philippe Mayaud; Laurent Bélec
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Mycoplasma genitalium infection among HIV-positive women: prevalence, risk factors and association with vaginal shedding.

Authors:  M Gatski; D H Martin; K Theall; A Amedee; R A Clark; J Dumestre; P Chhabra; N Schmidt; P Kissinger
Journal:  Int J STD AIDS       Date:  2011-03       Impact factor: 1.359

7.  Plasma and cervical viral loads among Ugandan and Zimbabwean women during acute and early HIV-1 infection.

Authors:  Charles S Morrison; Korey Demers; Cynthia Kwok; Stanley Bulime; Anne Rinaldi; Marshall Munjoma; Megan Dunbar; Tsungai Chipato; Josaphat Byamugisha; Barbara Van Der Pol; Eric Arts; Robert A Salata
Journal:  AIDS       Date:  2010-02-20       Impact factor: 4.177

Review 8.  Characteristics and quantities of HIV host cells in human genital tract secretions.

Authors:  Joseph A Politch; Jai Marathe; Deborah J Anderson
Journal:  J Infect Dis       Date:  2014-12-15       Impact factor: 5.226

9.  Permissive and protective factors associated with presence, level, and longitudinal pattern of cervicovaginal HIV shedding.

Authors:  James Homans; Shawna Christensen; Tracey Stiller; Chia-Hao Wang; Wendy Mack; Kathryn Anastos; Howard Minkoff; Mary Young; Ruth Greenblatt; Mardge Cohen; Howard Strickler; Roksana Karim; Lashonda Yvette Spencer; Eva Operskalski; Toinette Frederick; Andrea Kovacs
Journal:  J Acquir Immune Defic Syndr       Date:  2012-05-01       Impact factor: 3.731

10.  Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.

Authors:  Patricia Kissinger; Angela Amedee; Rebecca A Clark; Jeanne Dumestre; Katherine P Theall; Leann Myers; Michael E Hagensee; Thomas A Farley; David H Martin
Journal:  Sex Transm Dis       Date:  2009-01       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.